{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:29:06Z","timestamp":1783420146623,"version":"3.54.6"},"reference-count":55,"publisher":"SAGE Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s10227-005-0148-6","type":"journal-article","created":{"date-parts":[[2006,2,21]],"date-time":"2006-02-21T23:44:27Z","timestamp":1140565467000},"page":"209-214","source":"Crossref","is-referenced-by-count":39,"title":["Evaluation of the Effectiveness of Imiquimod and 5-Fluorouracil for the Treatment of Actinic Keratosis: Critical Review and Meta-analysis of Efficacy Studies"],"prefix":"10.1177","volume":"9","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Mcphail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2006,3,2]]},"reference":[{"key":"148_CR1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archinte.158.7.726","volume":"158","author":"SR Feldman","year":"1998","unstructured":"Feldman SR, Fleischer AB Jr, McConnell RC. Most common dermatologic problems identified by internists, 1990\u20131994. Arch Intern Med 1998; 158:726\u2013730","journal-title":"Arch Intern Med"},{"key":"148_CR2","first-page":"30","volume":"70","author":"AK. Gupta","year":"2002","unstructured":"Gupta AK. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation. Cutis 2002; 70:30\u201336","journal-title":"Cutis"},{"key":"148_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mjd.2000.103343","volume":"42","author":"RL. Moy","year":"2000","unstructured":"Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42:8\u201310","journal-title":"J Am Acad Dermatol"},{"key":"148_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","volume":"42","author":"SJ. Salasche","year":"2000","unstructured":"Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42:4\u20137","journal-title":"J Am Acad Dermatol"},{"key":"148_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1067\/mjd.2000.103338","volume":"42","author":"SM. Dinehart","year":"2000","unstructured":"Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000; 42:25\u201328","journal-title":"J Am Acad Dermatol"},{"key":"148_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0190-9622(95)90191-4","volume":"32","author":"LA Drake","year":"1995","unstructured":"Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for actinic keratoses. Committee on Guidelines of Care. J Am Acad Dermatol 1995; 32:95\u201398","journal-title":"Committee on Guidelines of Care. J Am Acad Dermatol"},{"key":"148_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0190-9622(99)70526-8","volume":"40","author":"SR Feldman","year":"1999","unstructured":"Feldman SR, Fleischer AB Jr, Williford PM, et al. Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol 1999; 40:43\u201347","journal-title":"J Am Acad Dermatol"},{"key":"148_CR8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archderm.1991.01680060105014","volume":"127","author":"R. Marks","year":"1991","unstructured":"Marks R. The role of treatment of actinic keratoses in the prevention of morbidity and mortality due to squamous cell carcinoma. Arch Dermatol 1991; 127:1031\u20131033","journal-title":"Arch Dermatol"},{"key":"148_CR9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archderm.1965.01600160066015","volume":"92","author":"CJ Dillaha","year":"1965","unstructured":"Dillaha CJ, Jansen GT, Honeycutt WM, et al. Further studies with topical 5-fluorouracil. Arch Dermatol 1965; 92:410\u2013417","journal-title":"Arch Dermatol"},{"key":"148_CR10","first-page":"1","volume":"6","author":"AK Gupta","year":"2001","unstructured":"Gupta AK, Weiss JS, Jorizzo JL. 5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp. Skin Therapy Lett 2001; 6:1\u20134","journal-title":"Skin Therapy Lett"},{"key":"148_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jso.2930030312","volume":"3","author":"GT. Jansen","year":"1971","unstructured":"Jansen GT. Topical therapy with 5-fluorouracil. J Surg Oncol 1971; 3:317\u2013323","journal-title":"J Surg Oncol"},{"key":"148_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00128071-200001030-00004","volume":"1","author":"EW Jeffes III","year":"2000","unstructured":"Jeffes EW III, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol 2000; 1:167\u2013179","journal-title":"Current treatment options. Am J Clin Dermatol"},{"key":"148_CR13","first-page":"335","volume":"70","author":"J Jorizzo","year":"2002","unstructured":"Jorizzo J, Stewart D, Bucko A, et al. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis 2002; 70:335\u2013339","journal-title":"Cutis"},{"key":"148_CR14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00007611-196910000-00020","volume":"62","author":"RE. Rossman","year":"1969","unstructured":"Rossman RE. Topical fluorouracil therapy. South Med J 1969; 62:1240\u20131242","journal-title":"South Med J"},{"key":"148_CR15","first-page":"22","volume":"70","author":"J Weiss","year":"2002","unstructured":"Weiss J, Menter A, Hevia O, et al. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis 2002; 70:22\u201329","journal-title":"Cutis"},{"key":"148_CR16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archderm.1970.04000020002002","volume":"101","author":"WH Eaglstein","year":"1970","unstructured":"Eaglstein WH, Weinstein GD, Frost P. Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo. Arch Dermatol 1970; 101:132\u2013139","journal-title":"Arch Dermatol"},{"key":"148_CR17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2000.107809","volume":"43","author":"MV. Dahl","year":"2000","unstructured":"Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000; 43:S1\u2013S5","journal-title":"J Am Acad Dermatol"},{"key":"148_CR18","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1067\/mjd.2002.126586","volume":"47","author":"MV. Dahl","year":"2002","unstructured":"Dahl MV. Imiquimod: a cytokine inducer. J Am Acad Dermatol 2002; 47:S205\u2013S208","journal-title":"J Am Acad Dermatol"},{"key":"148_CR19","first-page":"35","volume":"2","author":"JQ. Rosso Del","year":"2003","unstructured":"Del Rosso JQ. An update on newer topical therapies for actinic keratoses: advances and applications. J Drugs Dermatol 2003; 2:35\u201339","journal-title":"J Drugs Dermatol"},{"key":"148_CR20","first-page":"23","volume":"10","author":"MA. Stanley","year":"1999","unstructured":"Stanley MA. Mechanism of action of imiquimod. Papillomavirus Rep. 1999; 10:23\u201329","journal-title":"Papillomavirus Rep"},{"key":"148_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"148_CR22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0306-9877(91)90232-N","volume":"35","author":"V. Velanovich","year":"1991","unstructured":"Velanovich V. Meta-analysis for combining Bayesian probabilities. Med Hypotheses 1991; 35:192\u2013195","journal-title":"Med Hypotheses"},{"key":"148_CR23","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archderm.1976.01630330026006","volume":"112","author":"T Breza","year":"1976","unstructured":"Breza T, Taylor R, Eaglstein WH. Noninflammatory destruction of actinic keratoses by fluorouracil. Arch Dermatol 1976; 112:1256\u20131258","journal-title":"Arch Dermatol"},{"key":"148_CR24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","volume":"51","author":"RM Szeimies","year":"2004","unstructured":"Szeimies RM, Gerritsen MJ, Gupta G, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004; 51:547\u2013555","journal-title":"J Am Acad Dermatol"},{"key":"148_CR25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1995.01690140060009","volume":"131","author":"N Lawrence","year":"1995","unstructured":"Lawrence N, Cox SE, Cockerell CJ, et al. A comparison of the efficacy and safety of Jessner\u2019s solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 1995; 131:176\u2013181","journal-title":"Arch Dermatol"},{"key":"148_CR26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","volume":"50","author":"M Lebwohl","year":"2004","unstructured":"Lebwohl M, Dinehart S, Whiting D, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004; 50:714\u2013721","journal-title":"J Am Acad Dermatol"},{"key":"148_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/09546638909086695","volume":"1","author":"D Shuttleworth","year":"1989","unstructured":"Shuttleworth D, Marks R. A comparison of the effects of intralesional interferon alpha-2b and topical 5% 5-fluorouracil cream in the treatment of solar keratoses and Bowen\u2019s disease. J Dermatol Treat 1989; 1:65\u201368","journal-title":"J Dermatol Treat"},{"key":"148_CR28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1046\/j.1365-2133.2001.04197.x","volume":"144","author":"E Stockfleth","year":"2001","unstructured":"Stockfleth E, Meyer T, Benninghoff B, et al. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001; 144:1050\u20131053","journal-title":"Br J Dermatol"},{"key":"148_CR29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archderm.138.11.1498","volume":"138","author":"E Stockfleth","year":"2002","unstructured":"Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138:1498\u20131502","journal-title":"Arch Dermatol"},{"key":"148_CR30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1524-4725.1983.tb00824.x","volume":"9","author":"DM. Abadir","year":"1983","unstructured":"Abadir DM. Combination of topical 5-fluorouracil with cryotherapy for treatment of actinic keratoses. J Dermatol Surg Oncol 1983; 9:403\u2013404","journal-title":"J Dermatol Surg Oncol"},{"key":"148_CR31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1987.tb05876.x","volume":"116","author":"L. Bercovitch","year":"1987","unstructured":"Bercovitch L. Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-fluorouracil: a double-blind controlled study. Br J Dermatol 1987; 116:549\u2013552","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"148_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2230.28.s1.13.x","volume":"28","author":"L Bianchi","year":"2003","unstructured":"Bianchi L, Campione E, Marulli GC, et al. Actinic keratosis treated with an immune response modifier: a ease report of six patients. Clin Exp Dermatol 2003; 28(Suppl 1):39\u201341","journal-title":"Clin Exp Dermatol"},{"key":"148_CR33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1440-0960.2003.00003.x","volume":"44","author":"K Chen","year":"2003","unstructured":"Chen K, Yap LM, Marks R, et al. Short-course therapy with imiquimod 5% cream for solar keratoses: a randomized controlled trial. Australas J Dermatol 2003; 44:250\u2013255","journal-title":"Australas J Dermatol"},{"key":"148_CR34","first-page":"890","volume":"29","author":"J Eklind","year":"2003","unstructured":"Eklind J, Tartler U, Maschke J, et al. Imiquimod to treat different cancers of the epidermis. Dermatol Surg 2003; 29:890\u2013896","journal-title":"Dermatol Surg"},{"key":"148_CR35","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archderm.1977.01640070040002","volume":"113","author":"E. Epstein","year":"1977","unstructured":"Epstein E. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil. Arch Dermatol 1977; 113:906\u2013908","journal-title":"Arch Dermatol"},{"key":"148_CR36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0190-9622(99)70114-3","volume":"41","author":"HA Kurwa","year":"1999","unstructured":"Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41:414\u2013418","journal-title":"J Am Acad Dermatol"},{"key":"148_CR37","first-page":"517","volume":"30","author":"J Labandeira","year":"2004","unstructured":"Labandeira J, Pereiro M Jr, Valdes F, et al. Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Dermatol Surg 2004; 30:517\u2013520","journal-title":"Dermatol Surg"},{"key":"148_CR38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0149-2918(02)80012-1","volume":"24","author":"K Loven","year":"2002","unstructured":"Loven K, Stein L, Furst K, et al. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 2002; 24:990\u20131000","journal-title":"Clin Ther"},{"key":"148_CR39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0190-9622(91)70250-6","volume":"25","author":"DL. Pearlman","year":"1991","unstructured":"Pearlman DL. Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses. J Am Acad Dermatol 1991; 25:665\u2013667","journal-title":"J Am Acad Dermatol"},{"key":"148_CR40","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1067\/mjd.2002.126581","volume":"47","author":"A Persaud","year":"2002","unstructured":"Persaud A, Lebwohl M. Imiquimod cream in the treatment of actinic keratoses. J Am Acad Dermatol 2002; 47:S236\u2013S239","journal-title":"J Am Acad Dermatol"},{"key":"148_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mjd.2002.123492","volume":"47","author":"AN Persaud","year":"2002","unstructured":"Persaud AN, Shamuelova E, Sherer D, et al. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol 2002; 47:553\u2013556","journal-title":"J Am Acad Dermatol"},{"key":"148_CR42","first-page":"25","volume":"1","author":"P. Robins","year":"2002","unstructured":"Robins P. Pulse therapy with 5-FU in eradicating actinic keratoses with less than recommended dosage. J Drugs Dermatol 2002; 1:25\u201330","journal-title":"J Drugs Dermatol"},{"key":"148_CR43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2133.1975.tb03153.x","volume":"92","author":"TA Robinson","year":"1975","unstructured":"Robinson TA, Kligman AM. Treatment of solar keratoses of the extremities with retinoic acid and 5-fluorouracil. Br J Dermatol 1975; 92:703\u2013706","journal-title":"Br J Dermatol"},{"key":"148_CR44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2002.126257","volume":"47","author":"SJ Salasche","year":"2002","unstructured":"Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. J Am Acad Dermatol 2002; 47:571\u2013577","journal-title":"J Am Acad Dermatol"},{"key":"148_CR45","first-page":"629","volume":"2","author":"S Smith","year":"2003","unstructured":"Smith S, Piacquadio D, Morhenn V, et al. Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol 2003; 2:629\u2013635","journal-title":"J Drugs Dermatol"},{"key":"148_CR46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0030-4220(81)90362-5","volume":"52","author":"GR Warnock","year":"1981","unstructured":"Warnock GR, Fuller RP Jr, Pelleu GB Jr. Evaluation of 5-fluorouracil in the treatment of actinic keratosis of the lip. Oral Surg Oral Med Oral Pathol 1981; 52:501\u2013505","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"148_CR47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0895-4356(94)00172-M","volume":"48","author":"DJ Cook","year":"1995","unstructured":"Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 1995; 48:167\u2013171","journal-title":"J Clin Epidemiol"},{"key":"148_CR48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","volume":"323","author":"P Juni","year":"2001","unstructured":"Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42\u201346","journal-title":"BMJ"},{"key":"148_CR49","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-127-11-199712010-00008","volume":"127","author":"C Mulrow","year":"1997","unstructured":"Mulrow C, Langhorne P, Grimshaw J. Integrating heterogeneous pieces of evidence in systematic reviews. Ann Intern Med 1997; 127:989\u2013995","journal-title":"Ann Intern Med"},{"key":"148_CR50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1085-5629(03)00040-3","volume":"22","author":"S Silapunt","year":"2003","unstructured":"Silapunt S, Goldberg LH, Alam M. Topical and light-based treatments for actinic keratoses. Semin Cutan Med Surg 2003; 22:162\u2013170","journal-title":"Semin Cutan Med Surg"},{"key":"148_CR51","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0149-2918(01)80078-3","volume":"23","author":"S Levy","year":"2001","unstructured":"Levy S, Furst K, Chern W. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis. Clin Ther 2001; 23:908\u2013920","journal-title":"Clin Ther"},{"key":"148_CR52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0149-2918(01)80077-1","volume":"23","author":"S Levy","year":"2001","unstructured":"Levy S, Furst K, Chern W. A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clin Ther 2001; 23:901\u2013907","journal-title":"Clin Ther"},{"key":"148_CR53","first-page":"14","volume":"70","author":"S Levy","year":"2002","unstructured":"Levy S, Furst K, Chern W. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream. Cutis 2002; 70:14\u201321","journal-title":"Cutis"},{"key":"148_CR54","first-page":"737","volume":"10","author":"WL. Simmonds","year":"1972","unstructured":"Simmonds WL. Topical management of actinic keratoses with 5-fluorouracil: results of a 6-year follow-up study. Cutis 1972: 10:737\u2013742","journal-title":"Cutis"},{"key":"148_CR55","first-page":"4","volume":"70","author":"P Robins","year":"2002","unstructured":"Robins P, Gupta AK. The use of topical fluorouracil to treat actinic keratosis. Cutis x2002; 70:4\u20137","journal-title":"Cutis x"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1007\/s10227-005-0148-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T19:22:07Z","timestamp":1553282527000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10227-005-0148-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["148"],"URL":"https:\/\/doi.org\/10.1007\/s10227-005-0148-6","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}